Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.

The smart inhalers market is experiencing significant growth, driven by the increasing incidence of respiratory diseases like asthma and COPD, technological advancements, widespread smartphone usage, ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- The treatment-resistant depression market size has grown significantly over recent years. From $1.76 billion in 2024, it is ...

GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral ...

Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 ...

RFK Jr.'s upcoming MAHA report will address vaccines, ultra-processed foods, and children's health. Read more here.

Interest rates are heading downwards - to the glee of borrowers, but to the chagrin of the millions who need an income from their savings.

GSK’s new asset efimosfermin has already performed well in a Phase II trial, with the drugmaker saying it is now ‘Phase III ready’. Image credit: Getty/JUSTIN TALLIS. Just a day after dropping a $625m ...

GlaxoSmithKline Pharmaceuticals, the Indian arm of UK-based GSK, reported a 35% year-on-year jump in consolidated net profit for the fourth quarter of FY25, driven by robust growth in its ...

GSK’s linerixibat works by inhibiting the re-uptake of bile acids. Credit: MAXSHOT.PL / Shutterstock. GSK has reported positive outcomes from the randomised Phase III GLISTEN trial of the targeted ...